Interventional Oncology Market

Global Interventional Oncology Market Size, Trends & Analysis - Forecasts to 2026 By Product (Embolization Devices [Radioembolic Agents, Non-Radio Embolic Agents {Microspheres, Coated Beads, Microparticles}], Ablation Devices [Radiofrequency (RF) Ablation Devices, Microwave Ablation Devices, Cryoablation Devices, Other Ablation Devices], Support Devices [Microcatheters, Guidewires]), By Procedure (Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization, Transcatheter Arterial Radioembolization/ Selective Internal Radiation Therapy, Transcatheter Arterial Embolization/ Bland Embolization), By Cancer Type (Liver Cancer, Lung Cancer, Bone Metastasis, Kidney Cancer, Breast Cancer, Prostate Cancer, Other Cancers), By End-User (Hospitals, Academic & Research Institutions, Ambulatory Surgery Centers, Others), Vendor Landscape Company Market Share Analysis, and Competitor Analysis

Category Healthcare

Format

This report was recently updated on May 10 2024 with the latest and most recent market numbers

Interventional Oncology Market Insights

The global interventional oncology market size is projected to grow from USD 1.9 billion in 2021 to USD 2.9 billion by 2026 at a CAGR value of 8.3%. Interventional oncology offers minimally invasive, image-assisted diagnosis and treatment techniques for different types of cancer. Interventional oncology is carried out along with other cancer treatments such as surgery and chemotherapy. Interventional oncology enables quicker recovery, shorter hospital stays with minimal side effects for cancer patients.

The global interventional oncology market is driven by the growing number of patients suffering from cancer and the growing geriatric population. Technological advancements in the field of interventional oncology have allowed for increased product launches that have had s significantly positive impact on the global interventional oncology devices market. The growing demand for minimally invasive procedures to improve the comfort of the patient that does not cause unnecessary suffering has also had a hand in the growth of the global interventional oncology market. Along with the reduction in pain, interventional oncology procedures have a lower risk of complications, reduce recovery period for patients, as well as being a highly localized form of cancer treatment. Interventional oncology makes it possible for the removal of cancerous growth and lymph nodes with minimal to no scarring.

The growing number of cancer patients has increased the need for increased accessibility to cancer treatment for patients in developing and underdeveloped nations. Growing government funding for improving healthcare facilities and setting up public-private partnerships in developing nations offer lucrative opportunities for expansion for interventional oncology devices vendors.

The interventional oncology market is restrained by stringent regulations and slow approval processing times by government agencies for new products. The growing need for skilled oncologists and radiologists is another restraint on the growth of the global interventional oncology market. In India alone, there are over 1.8 million cancer patients who are being served by one oncologist for every 2000 patients. The situation is similar is true for most countries across the world and is often worse in other underdeveloped and developing nations. Clinical data that has been thoroughly vetted and can be used for developing patient treatment plans are very few which impacts the growth of the interventional oncology market.

global interventional market

Interventional Oncology Market: By Product

Interventional oncology technology has grown considerably in recent years and has resulted in various new products being available in the market. The interventional oncology market can be fragmented into embolization devices, ablation devices, and support devices. The embolization devices segment held the dominant share of the interventional oncology market. Embolization devices can be used to treat multiple forms of cancer as they make use of radioactive or non-radioactive material for cancer treatment. Embolization can be used when the cancer growth is too large and ablation therapy fails. These factors are the major contributors to the dominance of the embolization devices segment. This trend is expected to continue into the forecast period and result in the embolization devices segment growing significantly faster than the other segments.

Interventional Oncology Market: By Procedure

Based on the various procedures under interventional oncology, the market can be segmented as transcatheter arterial radioembolization/ selective internal radiation therapy, transcatheter arterial chemoembolization, thermal tumor ablation, transcatheter arterial embolization/ bland embolization, and non-thermal tumor ablation. The thermal tumor ablation segment is expected to show significantly quicker growth rates during the forecast period. Thermal tumor ablation offers significantly reduced hospitalization and is used extensively in treating lung and liver cancer.

Interventional Oncology Market: By Cancer Type

Various cancer types can be treated using interventional oncology, based on which the market can be segmented into liver cancer, lung cancer, bone metastasis, kidney cancer, breast cancer, prostate cancer, and other cancers. Liver cancer is envisaged to grasp the lion’s share of the market during the forecast period. Surgical removal of the cancer growth or tumor from the liver is not ideal for liver cancer as it can completely disrupt the working of the liver and leave it unable to serve its function. Interventional oncology procedures like thermal ablation can help to target tumor growth in the livers and leave healthy cells unharmed. This increased use of interventional oncology procedures to treat liver cancer has been one of the major drivers of the liver cancer segment.

Interventional Oncology Market: By End-User

Based on the end-users of interventional oncology, the market can be fragmented into hospitals, academic & research institutions, diagnostic centers, and others. The hospital segment held the dominant share of the interventional oncology market owing to the wide range of services that are offered at hospitals. Hospitals have significantly larger funding than the other segments which allows them to spend greater amounts to purchase state-of-the-art equipment and employ highly skilled employees to carry out interventional oncology procedures.

asia pacific interventional market

Interventional Oncology Market: By Region

The interventional oncology market can be categorized geographically as North America, Central & South America, Europe, Middle East & Africa, and Asia Pacific regions. The North American region held the dominant share of the interventional oncology market owing to the large geriatric population in the region and the growing incidence of cancer in the region. The region has witnessed heavy spending on healthcare infrastructure by the governments in the past few decades which has contributed to the dominance of this region over the interventional oncology market. The heavy spending on healthcare has allowed hospitals in the region to be well-staffed and provide some of the best interventional oncology facilities to their patients. A large number of key players in the interventional oncology market are situated in this region and spend heavily on the research and development of novel procedures and equipment which has contributed to the growth of this region.

The APAC region is envisaged to grow significantly faster than the other regions. The growing demand for minimally invasive cancer treatment procedures, the growing research work being carried out in the region on interventional oncology, the growing availability of interventional oncology products, and growing expenditure on healthcare are expected to be the major drivers of the interventional oncology market in the region.

Interventional Oncology Market Share and Competitor Analysis

Terumo, Merit Medical, Shape Memory Medical, AngioDynamics, ABK Biomedical, Boston Scientific, Guerbet, Profound Medical Corp, IceCure Medical, BD, Accuray, IMBiotechnologies, HealthTronics, Mermaid Medicals, Cook Medical, and Sanarus, among others are the key players in the interventional oncology market.

Please note: This is not an exhaustive list of companies profiled in the report.

Chapter 1 Methodology

1.1 Market Scope & Definitions

1.2 Estimates & Forecast Calculation

1.3 Historical Data Overview and Validation

1.4 Data Sources

1.4.1 Secondary

1.4.2 Primary

Chapter 2 Report Outlook

2.1 Interventional Oncology Industry Overview, 2020-2026

2.1.1 Industry Overview

2.1.2 Product Overview

2.1.3 Procedure Overview

2.1.4 End-User Overview

2.1.5 Cancer Type Overview

2.1.6 Regional Overview

Chapter 3 Interventional Oncology Market Trends

3.1 Market Segmentation

3.2 Industry Background, 2020-2026

3.3 Market Key Trends

3.3.1 Positive Trends

3.3.1.1 Advancements in interventional oncology technology and procedures

3.3.1.2 Growing number of patients suffering from cancer and the growing geriatric population

3.3.2 Industry Challenges

3.3.2.1 Lack of skilled oncologist and radiologists

3.4 Prospective Growth Scenario

3.4.1 Product Growth Scenario

3.4.2 Procedure Growth Scenario

3.4.3 End-User Growth Scenario

3.4.4 Cancer Type Growth Scenario

3.5 COVID-19 Influence over Industry Growth

3.6 Porter’s Analysis

3.7 PESTEL Analysis

3.8 Value Chain & Supply Chain Analysis

3.9 Regulatory Framework

3.9.1 North America

3.9.2 Europe

3.9.3 APAC

3.9.4 LATAM

3.9.5 MEA

3.10 Cancer Type Overview

3.11 Market Share Analysis, 2020

3.11.1 Company Positioning Overview, 2020

Chapter 4 Interventional Oncology Market, By Product

4.1 Product Outlook

4.2 Embolization Devices

4.2.1 Market Size, By Region, 2020-2026 (USD Billion)

4.3 Ablation Devices

4.3.1 Market Size, By Region, 2020-2026 (USD Billion)

4.4 Support Devices

4.4.1 Market Size, By Region, 2020-2026 (USD Billion)

Chapter 5 Interventional Oncology Market, By End-User

5.1 End-User Outlook

5.2 Hospitals

5.2.1 Market Size, By Region, 2020-2026 (USD Billion)

5.3 Ambulatory Surgery Centers

5.3.1 Market Size, By Region, 2020-2026 (USD Billion)

5.4 Academic & Research Institutions

5.4.1 Market Size, By Region, 2020-2026 (USD Billion)

5.5 Others

5.5.1 Market Size, By Region, 2020-2026 (USD Billion)

Chapter 6 Interventional Oncology Market, By Procedure

6.1 Thermal Tumor Ablation

6.1.1 Market Size, By Region, 2020-2026 (USD Billion)

6.2 Non-Thermal Tumor Ablation

6.2.1 Market Size, By Region, 2020-2026 (USD Billion)

6.3 Transcatheter Arterial Chemoembolization

6.3.1 Market Size, By Region, 2020-2026 (USD Billion)

6.4 Transcatheter Arterial Radioembolization

6.4.1 Market Size, By Region, 2020-2026 (USD Billion)

6.5 Transcatheter Arterial Embolization

6.5.1 Market Size, By Region, 2020-2026 (USD Billion)

Chapter 7 Interventional Oncology Market, By Cancer Type

7.1 Lung Cancer

7.1.1 Market Size, By Region, 2020-2026 (USD Billion)

7.2 Liver Cancer

7.2.1 Market Size, By Region, 2020-2026 (USD Billion)

7.3 Bone Metastasis

7.3.1 Market Size, By Region, 2020-2026 (USD Billion)

7.4 Kidney Cancer

7.4.1 Market Size, By Region, 2020-2026 (USD Billion)

7.5 Breast Cancer

7.5.1 Market Size, By Region, 2020-2026 (USD Billion)

7.6 Prostate Cancer

7.6.1 Market Size, By Region, 2020-2026 (USD Billion)

7.7 Other Cancers

7.7.1 Market Size, By Region, 2020-2026 (USD Billion)

Chapter 8 Interventional Oncology Market, By Region

8.1 Regional outlook

8.2 North America

8.2.1 Market Size, By Country 2020-2026 (USD Billion)

8.2.2 Market Size, By Product, 2020-2026 (USD Billion)

8.2.3 Market Size, By Procedure, 2020-2026 (USD Billion)

8.2.4 Market Size, By End-User, 2020-2026 (USD Billion)

8.2.5 Market Size, By Cancer Type, 2020-2026 (USD Billion)

8.2.6 U.S.

8.2.6.1 Market Size, By Product, 2020-2026 (USD Billion)

8.2.4.2 Market Size, By Procedure, 2020-2026 (USD Billion)

8.2.4.3 Market Size, By End-User, 2020-2026 (USD Billion)

Market Size, By Cancer Type, 2020-2026 (USD Billion)

8.2.7 Canada

8.2.7.1 Market Size, By Product, 2020-2026 (USD Billion)

8.2.7.2 Market Size, By Procedure, 2020-2026 (USD Billion)

8.2.7.3 Market Size, By End-User, 2020-2026 (USD Billion)

8.2.7.4 Market Size, By Cancer Type, 2020-2026 (USD Billion)

8.3 Europe

8.3.1 Market Size, By Country 2020-2026 (USD Billion)

8.3.2 Market Size, By Product, 2020-2026 (USD Billion)

8.3.3 Market Size, By Procedure, 2020-2026 (USD Billion)

8.3.4 Market Size, By End-User, 2020-2026 (USD Billion)

8.3.5 Market Size, By Cancer Type, 2020-2026 (USD Billion)

8.3.6 Germany

8.3.6.1 Market Size, By Product, 2020-2026 (USD Billion)

8.3.6.2 Market Size, By Procedure, 2020-2026 (USD Billion)

8.3.6.3 Market Size, By End-User, 2020-2026 (USD Billion)

8.3.6.4 Market Size, By Cancer Type, 2020-2026 (USD Billion)

8.3.7 UK

8.3.7.1 Market Size, By Product, 2020-2026 (USD Billion)

8.3.7.2 Market Size, By Procedure, 2020-2026 (USD Billion)

8.3.7.3 Market Size, By End-User, 2020-2026 (USD Billion)

8.3.7.4 Market Size, By Cancer Type, 2020-2026 (USD Billion)

8.3.8 France

8.3.8.1 Market Size, By Product, 2020-2026 (USD Billion)

8.3.8.2 Market Size, By Procedure, 2020-2026 (USD Billion)

8.3.8.3 Market Size, By End-User, 2020-2026 (USD Billion)

8.3.8.4 Market Size, By Cancer Type, 2020-2026 (USD Billion)

8.3.9 Italy

8.3.9.1 Market Size, By Product, 2020-2026 (USD Billion)

8.3.9.2 Market Size, By Procedure, 2020-2026 (USD Billion)

8.3.9.3 Market Size, By End-User, 2020-2026 (USD Billion)

8.3.9.4 Market Size, By Cancer Type, 2020-2026 (USD Billion)

8.3.10 Spain

8.3.10.1 Market Size, By Product, 2020-2026 (USD Billion)

8.3.10.2 Market Size, By Procedure, 2020-2026 (USD Billion)

8.3.10.3 Market Size, By End-User, 2020-2026 (USD Billion)

8.3.10.4 Market Size, By Cancer Type, 2020-2026 (USD Billion)

8.3.11 Russia

8.3.11.1 Market Size, By Product, 2020-2026 (USD Billion)

8.3.11.2 Market Size, By Procedure, 2020-2026 (USD Billion)

8.3.11.3 Market Size, By End-User, 2020-2026 (USD Billion)

8.3.11.4 Market Size, By Cancer Type, 2020-2026 (USD Billion)

8.4 Asia Pacific

8.4.1 Market Size, By Country 2020-2026 (USD Billion)

8.4.2 Market Size, By Product, 2020-2026 (USD Billion)

8.4.3 Market Size, By Procedure, 2020-2026 (USD Billion)

8.4.4 Market Size, By End-User, 2020-2026 (USD Billion)

8.4.5 Market Size, By Cancer Type, 2020-2026 (USD Billion)

8.4.6 China

8.4.6.1 Market Size, By Product, 2020-2026 (USD Billion)

8.4.6.2 Market Size, By Procedure, 2020-2026 (USD Billion)

8.4.6.3 Market Size, By End-User, 2020-2026 (USD Billion)

8.4.6.4 Market Size, By Cancer Type, 2020-2026 (USD Billion)

8.4.7 India

8.4.7.1 Market Size, By Product, 2020-2026 (USD Billion)

8.4.7.2 Market Size, By Procedure, 2020-2026 (USD Billion)

8.4.7.3 Market Size, By End-User, 2020-2026 (USD Billion)

8.4.7.4 Market Size, By Cancer Type, 2020-2026 (USD Billion)

8.4.8 Japan

8.4.8.1 Market Size, By Product, 2020-2026 (USD Billion)

8.4.8.2 Market Size, By Procedure, 2020-2026 (USD Billion)

8.4.8.3 Market Size, By End-User, 2020-2026 (USD Billion)

8.4.8.4 Market Size, By Cancer Type, 2020-2026 (USD Billion)

8.4.9 Australia

8.4.9.1 Market Size, By Product, 2020-2026 (USD Billion)

8.4.9.2 Market size, By Procedure, 2020-2026 (USD Billion)

8.4.9.3 Market Size, By End-User, 2020-2026 (USD Billion)

8.4.9.4 Market Size, By Cancer Type, 2020-2026 (USD Billion)

8.4.10 South Korea

8.4.10.1 Market Size, By Product, 2020-2026 (USD Billion)

8.4.10.2 Market Size, By Procedure, 2020-2026 (USD Billion)

8.4.10.3 Market Size, By End-User, 2020-2026 (USD Billion)

8.4.10.4 Market Size, By Cancer Type, 2020-2026 (USD Billion)

8.5 Latin America

8.5.1 Market Size, By Country 2020-2026 (USD Billion)

8.5.2 Market Size, By Product, 2020-2026 (USD Billion)

8.5.3 Market Size, By Procedure, 2020-2026 (USD Billion)

8.5.4 Market Size, By End-User, 2020-2026 (USD Billion)

8.5.5 Market Size, By Cancer Type, 2020-2026 (USD Billion)

8.5.6 Brazil

8.5.6.1 Market Size, By Product, 2020-2026 (USD Billion)

8.5.6.2 Market Size, By Procedure, 2020-2026 (USD Billion)

8.5.6.3 Market Size, By End-User, 2020-2026 (USD Billion)

8.5.6.4 Market Size, By Cancer Type, 2020-2026 (USD Billion)

8.5.7 Mexico

8.5.7.1 Market Size, By Product, 2020-2026 (USD Billion)

8.5.7.2 Market Size, By Procedure, 2020-2026 (USD Billion)

8.5.7.3 Market Size, By End-User, 2020-2026 (USD Billion)

8.5.7.4 Market Size, By Cancer Type, 2020-2026 (USD Billion)

8.5.8 Argentina

8.5.8.1 Market Size, By Product, 2020-2026 (USD Billion)

8.5.8.2 Market Size, By Procedure, 2020-2026 (USD Billion)

8.5.8.3 Market Size, By End-User, 2020-2026 (USD Billion)

8.5.8.4 Market Size, By Cancer Type, 2020-2026 (USD Billion)

8.6 MEA

8.6.1 Market Size, By Country 2020-2026 (USD Billion)

8.6.2 Market Size, By Product, 2020-2026 (USD Billion)

8.6.3 Market Size, By Procedure, 2020-2026 (USD Billion)

8.6.4 Market Size, By End-User, 2020-2026 (USD Billion)

8.6.5 Market Size, By Cancer Type, 2020-2026 (USD Billion)

8.6.6 Saudi Arabia

8.6.6.1 Market Size, By Product, 2020-2026 (USD Billion)

8.6.6.2 Market Size, By Procedure, 2020-2026 (USD Billion)

8.6.6.3 Market Size, By End-User, 2020-2026 (USD Billion)

8.6.6.4 Market Size, By Cancer Type, 2020-2026 (USD Billion)

8.6.7 UAE

8.6.7.1 Market Size, By Product, 2020-2026 (USD Billion)

8.6.7.2 Market Size, By Procedure, 2020-2026 (USD Billion)

8.6.7.3 Market Size, By End-User, 2020-2026 (USD Billion)

8.6.7.4 Market Size, By Cancer Type, 2020-2026 (USD Billion)

8.6.8 South Africa

8.6.8.1 Market Size, By Product, 2020-2026 (USD Billion)

8.6.8.2 Market Size, By Procedure, 2020-2026 (USD Billion)

8.6.8.3 Market Size, By End-User, 2020-2026 (USD Billion)

8.6.8.4 Market Size, By Cancer Type, 2020-2026 (USD Billion)

Chapter 9 Company Landscape

9.1 Competitive Analysis, 2020

9.2 Terumo

9.2.1 Company Overview

9.2.2 Financial Analysis

9.2.3 Strategic Positioning

9.2.4 Info Graphic Analysis

9.3 Merit Medical

9.3.1 Company Overview

9.3.2 Financial Analysis

9.3.3 Strategic Positioning

9.3.4 Info Graphic Analysis

9.4 Shape Memory Medical

9.4.1 Company Overview

9.4.2 Financial Analysis

9.4.3 Strategic Positioning

9.4.4 Info Graphic Analysis

9.5 AngioDynamics

9.5.1 Company Overview

9.5.2 Financial Analysis

9.5.3 Strategic Positioning

9.5.4 Info Graphic Analysis

9.6 ABK Biomedical

9.6.1 Company Overview

9.6.2 Financial Analysis

9.6.3 Strategic Positioning

9.6.4 Info Graphic Analysis

9.7 Boston Scientific

9.7.1 Company Overview

9.7.2 Financial Analysis

9.7.3 Strategic Positioning

9.7.4 Info Graphic Analysis

9.8 Guerbet

9.8.1 Company Overview

9.8.2 Financial Analysis

9.8.3 Strategic Positioning

9.8.4 Info Graphic Analysis

9.9 Profound Medical Corp

9.9.1 Company Overview

9.9.2 Financial Analysis

9.9.3 Strategic Positioning

9.9.4 Info Graphic Analysis

9.10 IceCure Medical

9.10.1 Company Overview

9.10.2 Financial Analysis

9.10.3 Strategic Positioning

9.10.4 Info Graphic Analysis

9.11 Other Companies

9.11.1 Company Overview

9.11.2 Financial Analysis

9.11.3 Strategic Positioning

9.11.4 Info Graphic Analysis

The Global Interventional Oncology Market has been studied from the year 2019 till 2026. However, the CAGR provided in the report is from the year 2021 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Interventional Oncology Market.

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe. Privacy

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

What is the projected market size of the global interventional oncology market?

The global interventional oncology market size is projected to grow from USD 1.9 billion in 2021 to USD 2.9 billion by 2026, at a CAGR of 8.3% during the forecast period.

Who are the major vendors in the interventional oncology market?

Key and innovative vendors in the interventional oncology market include Terumo, Merit Medical, Shape Memory Medical, AngioDynamics, ABK Biomedical, Boston Scientific, Guerbet, Profound Medical Corp, IceCure Medical, BD, Accuray, IMBiotechnologies, HealthTronics, Mermaid Medicals, Cook Medical, and Sanarus.

Which region has the highest market share in the interventional oncology market?

North America is estimated to hold the highest market share in the interventional oncology market.

What is the Covid-19 impact on future interventional oncology manufacturers?

Globally, Covid-19 impact on the future interventional oncology market will be quite significant for the manufacturers. North America would be leading because of the large number of key players spending heavily on the research and development of novel procedures and equipment Subsequently, the Asia Pacific market will be growing the fastest because of the growing availability of interventional oncology products, and rising expenditure on healthcare.

What are the major drivers in the interventional oncology market?

The major driving factors for the interventional oncology market include a growing number of patients suffering from cancer, a soaring proportion of the geriatric population; increasing need for minimally invasive treatment procedures; Technological advancements in the field of interventional oncology, and novel procedures; growing availability of interventional oncology products; growing government funding for improving healthcare facilities and setting up public-private partnerships.